A detailed history of Scarborough Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Scarborough Advisors, LLC holds 770 shares of ABT stock, worth $86,548. This represents 0.03% of its overall portfolio holdings.

Number of Shares
770
Previous 761 1.18%
Holding current value
$86,548
Previous $86,000 6.98%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $906 - $1,011
9 Added 1.18%
770 $80,000
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $109 - $120
1 Added 0.13%
761 $86,000
Q4 2023

Feb 29, 2024

SELL
$90.19 - $110.4 $522,019 - $638,995
-5,788 Reduced 88.39%
760 $83,000
Q4 2023

Feb 22, 2024

BUY
$90.19 - $110.4 $590,564 - $722,899
6,548 New
6,548 $720,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Scarborough Advisors, LLC Portfolio

Follow Scarborough Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scarborough Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scarborough Advisors, LLC with notifications on news.